Top

Published in:

01-02-2013 | Original Article

Preconditioning for Traumatic Brain Injury

Authors: Shoji Yokobori, Anna T Mazzeo, Khadil Hosein, Shyam Gajavelli, W. Dalton Dietrich, M. Ross Bullock

Published in: Translational Stroke Research | Issue 1/2013

Abstract

Traumatic brain injury (TBI) treatment is now focused on the prevention of primary injury and reduction of secondary injury. However, no single effective treatment is available as yet for the mitigation of traumatic brain damage in humans. Both chemical and environmental stresses applied before injury have been shown to induce consequent protection against post-TBI neuronal death. This concept termed “preconditioning” is achieved by exposure to different pre-injury stressors to achieve the induction of “tolerance” to the effect of the TBI. However, the precise mechanisms underlying this “tolerance” phenomenon are not fully understood in TBI, and therefore even less information is available about possible indications in clinical TBI patients. In this review, we will summarize TBI pathophysiology, and discuss existing animal studies demonstrating the efficacy of preconditioning in diffuse and focal type of TBI. We will also review other non-TBI preconditioning studies, including ischemic, environmental, and chemical preconditioning, which maybe relevant to TBI. To date, no clinical studies exist in this field, and we speculate on possible future clinical situations, in which pre-TBI preconditioning could be considered.

Langlois JA, Marr A, Mitchko J, Johnson RL. Tracking the silent epidemic and educating the public: CDC’s traumatic brain injury-associated activities under the TBI Act of 1996 and the Children’s Health Act of 2000. J Head Trauma Rehabil. 2005;20(3):196–204.PubMedCrossRef

Binder S, Corrigan JD, Langlois JA. The public health approach to traumatic brain injury: an overview of CDC’s research and programs. J Head Trauma Rehabil. 2005;20(3):189–95.PubMedCrossRef

Fu ES, Tummala RP. Neuroprotection in brain and spinal cord trauma. Curr Opin Anaesthesiol. 2005;18(2):181–7. doi:10.1097/01.aco.0000162838.56344.88.PubMedCrossRef

Vink R, Nimmo AJ. Multifunctional drugs for head injury. Neurotherapeutics. 2009;6(1):28–42. doi:10.1016/j.nurt.2008.10.036.PubMedCrossRef

Cole TB. Global road safety crisis remedy sought: 1.2 million killed, 50 million injured annually. JAMA. 2004;291(21):2531–2. doi:10.1001/jama.291.21.2531.PubMedCrossRef

Mar J, Arrospide A, Begiristain JM, Larranaga I, Elosegui E, Oliva-Moreno J. The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life. BMC Neurol. 2011;11:46. doi:10.1186/1471-2377-11-46.PubMedCrossRef

Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, et al. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol. 2011;10(2):131–9. doi:10.1016/s1474-4422(10)70300-8.PubMedCrossRef

Janoff A. Alterations in lysosomes (intracellular enzymes) during shock; effects of preconditioning (tolerance) and protective drugs. Int Anesthesiol Clin. 1964;2:251–69.PubMedCrossRef

Perez-Pinzon MA, Alonso O, Kraydieh S, Dietrich WD. Induction of tolerance against traumatic brain injury by ischemic preconditioning. Neuroreport. 1999;10(14):2951–4.PubMedCrossRef

10.

Perez-Pinzon MA. Neuroprotective effects of ischemic preconditioning in brain mitochondria following cerebral ischemia. J Bioenerg Biomembr. 2004;36(4):323–7. doi:10.1023/B:JOBB.0000041762.47544.ff.PubMedCrossRef

11.

Correia SC, Carvalho C, Cardoso S, Santos RX, Santos MS, Oliveira CR et al. Mitochondrial preconditioning: a potential neuroprotective strategy. Front Aging Neurosci, 2010; 2. doi:10.3389/fnagi.2010.00138.

12.

Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA. Mitochondria: the missing link between preconditioning and neuroprotection. J Alzheimers Dis. 2010;20 Suppl 2:S475–85. doi:10.3233/jad-2010-100669.PubMed

13.

Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009;8(4):398–412. doi:10.1016/s1474-4422(09)70054-7.PubMedCrossRef

14.

Lindenberg R, Freytag E. The mechanism of cerebral contusions. A pathologic-anatomic study. Arch Pathol. 1960;69:440–69.PubMed

15.

Maloney AF, Whatmore WJ. Clinical and pathological observations in fatal head injuries. A 5-year survey of 173 cases. Br J Surg. 1969;56(1):23–31.PubMedCrossRef

16.

Freytag E. Autopsy findings in head injuries from firearms. Statistical evaluation of 254 cases. Arch Pathol. 1963;76:215–25.PubMed

17.

Adams JH, Graham DI, Scott G, Parker LS, Doyle D. Brain damage in fatal non-missile head injury. J Clin Pathol. 1980;33(12):1132–45.PubMedCrossRef

18.

Strich SJ. Diffuse degeneration of the cerebral white matter in severe dementia following head injury. J Neurol Neurosurg Psychiatry. 1956;19(3):163–85.PubMedCrossRef

19.

Gennarelli TA. Mechanisms of brain injury. J Emerg Med. 1993;11 Suppl 1:5–11.PubMed

20.

Pettus EH, Christman CW, Giebel ML, Povlishock JT. Traumatically induced altered membrane permeability: its relationship to traumatically induced reactive axonal change. J Neurotrauma. 1994;11(5):507–22.PubMedCrossRef

21.

Povlishock JT, Christman CW. The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts. J Neurotrauma. 1995;12(4):555–64.PubMedCrossRef

22.

Kampfl A, Posmantur RM, Zhao X, Schmutzhard E, Clifton GL, Hayes RL. Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. J Neurotrauma. 1997;14(3):121–34.PubMedCrossRef

23.

Maxwell WL, Povlishock JT, Graham DL. A mechanistic analysis of nondisruptive axonal injury: a review. J Neurotrauma. 1997;14(7):419–40.PubMedCrossRef

24.

Buki A, Siman R, Trojanowski JQ, Povlishock JT. The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J Neuropathol Exp Neurol. 1999;58(4):365–75.PubMedCrossRef

25.

Shields DC, Schaecher KE, Hogan EL, Banik NL. Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J Neurosci Res. 2000;61(2):146–50.PubMedCrossRef

26.

Saatman KE, Creed J, Raghupathi R. Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics. 2010;7(1):31–42. doi:10.1016/j.nurt.2009.11.002.PubMedCrossRef

27.

Kilinc D, Gallo G, Barbee KA. Mechanical membrane injury induces axonal beading through localized activation of calpain. Exp Neurol. 2009;219(2):553–61. doi:10.1016/j.expneurol.2009.07.014.PubMedCrossRef

28.

Okonkwo DO, Povlishock JT. An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J Cereb Blood Flow Metab. 1999;19(4):443–51. doi:10.1097/00004647-199904000-00010.PubMedCrossRef

29.

Buki A, Okonkwo DO, Wang KK, Povlishock JT. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci. 2000;20(8):2825–34.PubMed

30.

Raghupathi R. Cell death mechanisms following traumatic brain injury. Brain Pathol. 2004;14(2):215–22.PubMedCrossRef

31.

Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1(8):623–34.PubMedCrossRef

32.

Willis C, Lybrand S, Bellamy N. Excitatory amino acid inhibitors for traumatic brain injury. Cochrane Database Syst Rev, 2004; (1):CD003986. doi:10.1002/14651858.CD003986.pub2.

33.

Moojen VK, Damiani-Neves M, Bavaresco DV, Pescador BB, Comim CM, Quevedo J, et al. NMDA preconditioning prevents object recognition memory impairment and increases brain viability in mice exposed to traumatic brain injury. Brain Res. 2012;1466:82–90. doi:10.1016/j.brainres.2012.05.041.PubMedCrossRef

34.

Adelson PD, Robichaud P, Hamilton RL, Kochanek PM. A model of diffuse traumatic brain injury in the immature rat. J Neurosurg. 1996;85(5):877–84. doi:10.3171/jns.1996.85.5.0877.PubMedCrossRef

35.

Costa T, Constantino LC, Mendonca BP, Pereira JG, Herculano B, Tasca CI, et al. N-methyl-d-aspartate preconditioning improves short-term motor deficits outcome after mild traumatic brain injury in mice. J Neurosci Res. 2010;88(6):1329–37. doi:10.1002/jnr.22300.PubMed

36.

Boeck CR, Kroth EH, Bronzatto MJ, Vendite D. Effect of the L- or D-aspartate on ecto-5’nucleotidase activity and on cellular viability in cultured neurons: participation of the adenosine A(2A) receptors. Amino Acids. 2007;33(3):439–44. doi:10.1007/s00726-006-0455-2.PubMedCrossRef

37.

Shohami E, Novikov M, Horowitz M. Long term exposure to heat reduces edema formation after closed head injury in the rat. Acta Neurochir Suppl (Wien). 1994;60:443–5.

38.

Shein NA, Horowitz M, Alexandrovich AG, Tsenter J, Shohami E. Heat acclimation increases hypoxia-inducible factor 1alpha and erythropoietin receptor expression: implication for neuroprotection after closed head injury in mice. J Cereb Blood Flow Metab. 2005;25(11):1456–65. doi:10.1038/sj.jcbfm.9600142.PubMedCrossRef

39.

Su Z, Han D, Sun B, Qiu J, Li Y, Li M, et al. Heat stress preconditioning improves cognitive outcome after diffuse axonal injury in rats. J Neurotrauma. 2009;26(10):1695–706. doi:10.1089/neu.2008.0519.PubMedCrossRef

40.

Hu SL, Hu R, Li F, Liu Z, Xia YZ, Cui GY, et al. Hyperbaric oxygen preconditioning protects against traumatic brain injury at high altitude. Acta Neurochir Suppl. 2008;105:191–6.PubMedCrossRef

41.

Clausen F, Lorant T, Lewen A, Hillered L. T lymphocyte trafficking: a novel target for neuroprotection in traumatic brain injury. J Neurotrauma. 2007;24(8):1295–307. doi:10.1089/neu.2006.0258.PubMedCrossRef

42.

Lu J, Goh SJ, Tng PY, Deng YY, Ling EA, Moochhala S. Systemic inflammatory response following acute traumatic brain injury. Front Biosci. 2009;14:3795–813.CrossRef

43.

Raghupathi R, Graham DI, McIntosh TK. Apoptosis after traumatic brain injury. J Neurotrauma. 2000;17(10):927–38.PubMedCrossRef

44.

Kawamata T, Katayama Y, Hovda DA, Yoshino A, Becker DP. Lactate accumulation following concussive brain injury: the role of ionic fluxes induced by excitatory amino acids. Brain Res. 1995;674(2):196–204.PubMedCrossRef

45.

Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A. 1994;91(22):10625–9.PubMedCrossRef

46.

Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A. 1995;92(16):7162–6.PubMedCrossRef

47.

Longhi L, Gesuete R, Perego C, Ortolano F, Sacchi N, Villa P, et al. Long-lasting protection in brain trauma by endotoxin preconditioning. J Cereb Blood Flow Metab. 2011;31(9):1919–29. doi:10.1038/jcbfm.2011.42.PubMedCrossRef

48.

Miller JD, Bullock R, Graham DI, Chen MH, Teasdale GM. Ischemic brain damage in a model of acute subdural hematoma. Neurosurgery. 1990;27(3):433–9.PubMedCrossRef

49.

Kuroda Y, Bullock R. Local cerebral blood flow mapping before and after removal of acute subdural hematoma in the rat. Neurosurgery. 1992;30(5):687–91.PubMedCrossRef

50.

Burger R, Bendszus M, Vince GH, Solymosi L, Roosen K. Neurophysiological monitoring, magnetic resonance imaging, and histological assays confirm the beneficial effects of moderate hypothermia after epidural focal mass lesion development in rodents. Neurosurgery. 2004;54(3):701–11. discussion 11–2.PubMedCrossRef

51.

Kuroda Y, Fujisawa H, Strebel S, Graham DI, Bullock R. Effect of neuroprotective N-methyl-d-aspartate antagonists on increased intracranial pressure: studies in the rat acute subdural hematoma model. Neurosurgery. 1994;35(1):106–12.PubMedCrossRef

52.

Yokobori S, Frantzen J, Bullock R, Gajavelli S, Burks S, Bramlett H, et al. The use of hypothermia therapy in traumatic ischemic/reperfusional brain injury: review of the literatures. Therapeutic Hypothermia And Temperature Management. 2011;1(4):185–92. doi:10.1089/ther.2011.0012.PubMedCrossRef

53.

Lampe JW, Becker LB. State of the art in therapeutic hypothermia. Annu Rev Med. 2011;62:79–93. doi:10.1146/annurev-med-052009-150512.PubMedCrossRef

54.

Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009;37(7 Suppl):S186–202. doi:10.1097/CCM.0b013e3181aa5241.PubMedCrossRef

55.

Badruddin A, Taqi MA, Abraham MG, Dani D, Zaidat OO. Neurocritical care of a reperfused brain. Curr Neurol Neurosci Rep. 2011;11(1):104–10. doi:10.1007/s11910-010-0156-9.PubMedCrossRef

56.

Simon RP. Acidotoxicity trumps excitotoxicity in ischemic brain. Arch Neurol. 2006;63(10):1368–71. doi:10.1001/archneur.63.10.1368.PubMedCrossRef

57.

Wahlgren NG, Ahmed N. Neuroprotection in cerebral ischaemia: facts and fancies—the need for new approaches. Cerebrovasc Dis. 2004;17 Suppl 1:153–66. doi:10.1159/000074808.PubMedCrossRef

58.

Leker RR, Shohami E. Cerebral ischemia and trauma—different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Brain Res Rev. 2002;39(1):55–73.PubMedCrossRef

59.

Wong CH, Crack PJ. Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Curr Med Chem. 2008;15(1):1–14.PubMedCrossRef

60.

Brennan AM, Suh SW, Won SJ, Narasimhan P, Kauppinen TM, Lee H, et al. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci. 2009;12(7):857–63. doi:10.1038/nn.2334.PubMedCrossRef

61.

Eldadah BA, Faden AI. Caspase pathways, neuronal apoptosis, and CNS injury. J Neurotrauma. 2000;17(10):811–29.PubMedCrossRef

62.

Tuttolomondo A, Di Sciacca R, Di Raimondo D, Arnao V, Renda C, Pinto A, et al. Neuron protection as a therapeutic target in acute ischemic stroke. Curr Top Med Chem. 2009;9(14):1317–34.PubMedCrossRef

63.

Bolli R, Jeroudi MO, Patel BS, Aruoma OI, Halliwell B, Lai EK, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial “stunning” is a manifestation of reperfusion injury. Circ Res. 1989;65(3):607–22.PubMedCrossRef

64.

Khalid MA, Ashraf M. Direct detection of endogenous hydroxyl radical production in cultured adult cardiomyocytes during anoxia and reoxygenation. Is the hydroxyl radical really the most damaging radical species? Circ Res. 1993;72(4):725–36.PubMedCrossRef

65.

Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 1994;344(8924):721–4.PubMedCrossRef

66.

Sugawara T, Chan PH. Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid Redox Signal. 2003;5(5):597–607. doi:10.1089/152308603770310266.PubMedCrossRef

67.

Huang Y, Rabb H, Womer KL. Ischemia–reperfusion and immediate T cell responses. Cell Immunol. 2007;248(1):4–11. doi:10.1016/j.cellimm.2007.03.009.PubMedCrossRef

68.

Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, Song YS, et al. Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol. 2010;41(2–3):172–9. doi:10.1007/s12035-010-8102-z.PubMedCrossRef

69.

Lv M, Liu Y, Zhang J, Sun L, Liu Z, Zhang S, et al. Roles of inflammation response in microglia cell through Toll-like receptors 2/interleukin-23/interleukin-17 pathway in cerebral ischemia/reperfusion injury. Neuroscience. 2011;176:162–72. doi:10.1016/j.neuroscience.2010.11.066.PubMedCrossRef

70.

Chaudhry K, Rogers R, Guo M, Lai Q, Goel G, Liebelt B, et al. Matrix metalloproteinase-9 (MMP-9) expression and extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation in exercise-reduced neuronal apoptosis after stroke. Neurosci Lett. 2010;474(2):109–14. doi:10.1016/j.neulet.2010.03.020.PubMedCrossRef

71.

Curry A, Guo M, Patel R, Liebelt B, Sprague S, Lai Q, et al. Exercise pre-conditioning reduces brain inflammation in stroke via tumor necrosis factor-alpha, extracellular signal-regulated kinase 1/2 and matrix metalloproteinase-9 activity. Neurol Res. 2010;32(7):756–62. doi:10.1179/174313209x459101.PubMedCrossRef

72.

Davis W, Mahale S, Carranza A, Cox B, Hayes K, Jimenez D, et al. Exercise pre-conditioning ameliorates blood–brain barrier dysfunction in stroke by enhancing basal lamina. Neurol Res. 2007;29(4):382–7. doi:10.1179/016164107x204701.PubMedCrossRef

73.

Ding Y, Li J, Luan X, Ding YH, Lai Q, Rafols JA, et al. Exercise pre-conditioning reduces brain damage in ischemic rats that may be associated with regional angiogenesis and cellular overexpression of neurotrophin. Neuroscience. 2004;124(3):583–91. doi:10.1016/j.neuroscience.2003.12.029.PubMedCrossRef

74.

Dornbos 3rd D, Ding Y. Mechanisms of neuronal damage and neuroprotection underlying ischemia/reperfusion injury after physical exercise. Curr Drug Targets. 2012;13(2):247–62.PubMedCrossRef

75.

Bramlett HM, Green EJ, Dietrich WD, Busto R, Globus MY, Ginsberg MD. Posttraumatic brain hypothermia provides protection from sensorimotor and cognitive behavioral deficits. J Neurotrauma. 1995;12(3):289–98.PubMedCrossRef

76.

Dietrich WD, Alonso O, Busto R, Globus MY, Ginsberg MD. Post-traumatic brain hypothermia reduces histopathological damage following concussive brain injury in the rat. Acta Neuropathol. 1994;87(3):250–8.PubMedCrossRef

77.

Dietrich WD, Bramlett HM. The evidence for hypothermia as a neuroprotectant in traumatic brain injury. Neurotherapeutics. 2010;7(1):43–50. doi:10.1016/j.nurt.2009.10.015.PubMedCrossRef

78.

Jia F, Mao Q, Liang YM, Jiang JY. Effect of post-traumatic mild hypothermia on hippocampal cell death after traumatic brain injury in rats. J Neurotrauma. 2009;26(2):243–52. doi:10.1089/neu.2008.0670.PubMedCrossRef

79.

Okauchi M, Kawai N, Nakamura T, Kawanishi M, Nagao S. Effects of mild hypothermia and alkalizing agents on brain injuries in rats with acute subdural hematomas. J Neurotrauma. 2002;19(6):741–51. doi:10.1089/08977150260139110.PubMedCrossRef

80.

Karibe H, Zarow GJ, Graham SH, Weinstein PR. Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood–brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1994;14(4):620–7. doi:10.1038/jcbfm.1994.77.PubMedCrossRef

81.

Kawai N, Nakamura T, Okauchi M, Nagao S. Effects of hypothermia on intracranial pressure and brain edema formation: studies in a rat acute subdural hematoma model. J Neurotrauma. 2000;17(3):193–202.PubMedCrossRef

82.

Alkhulaifi AM, Pugsley WB, Yellon DM. The influence of the time period between preconditioning ischemia and prolonged ischemia on myocardial protection. Cardioscience. 1993;4(3):163–9.PubMed

83.

Kato H, Araki T, Murase K, Kogure K. Induction of tolerance to ischemia: alterations in second-messenger systems in the gerbil hippocampus. Brain Res Bull. 1992;29(5):559–65.PubMedCrossRef

84.

Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, et al. ‘Ischemic tolerance’ phenomenon found in the brain. Brain Res. 1990;528(1):21–4.PubMedCrossRef

85.

Lin B, Dietrich WD, Ginsberg MD, Globus MY, Busto R. MK-801 (dizocilpine) protects the brain from repeated normothermic global ischemic insults in the rat. J Cereb Blood Flow Metab. 1993;13(6):925–32. doi:10.1038/jcbfm.1993.115.PubMedCrossRef

86.

Lin B, Globus MY, Dietrich WD, Busto R, Martinez E, Ginsberg MD. Differing neurochemical and morphological sequelae of global ischemia: comparison of single- and multiple-insult paradigms. J Neurochem. 1992;59(6):2213–23.PubMedCrossRef

87.

88.

Dave KR, Lange-Asschenfeldt C, Raval AP, Prado R, Busto R, Saul I, et al. Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate/gamma-aminobutyric acid release and biosynthesis. J Neurosci Res. 2005;82(5):665–73. doi:10.1002/jnr.20674.PubMedCrossRef

89.

DeFazio RA, Raval AP, Lin HW, Dave KR, Della-Morte D, Perez-Pinzon MA. GABA synapses mediate neuroprotection after ischemic and epsilonPKC preconditioning in rat hippocampal slice cultures. J Cereb Blood Flow Metab. 2009;29(2):375–84. doi:10.1038/jcbfm.2008.126.PubMedCrossRef

90.

Fanne RA, Nassar T, Mazuz A, Waked O, Heyman SN, Hijazi N, et al. Neuroprotection by glucagon: role of gluconeogenesis. J Neurosurg. 2011;114(1):85–91. doi:10.3171/2010.4.jns10263.PubMedCrossRef

91.

Umschwief G, Shein NA, Alexandrovich AG, Trembovler V, Horowitz M, Shohami E. Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury. J Cereb Blood Flow Metab. 2010;30(3):616–27. doi:10.1038/jcbfm.2009.234.PubMedCrossRef

92.

Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care. 2002;8(2):101–5.PubMedCrossRef

93.

Yan EB, Hellewell SC, Bellander BM, Agyapomaa DA, Morganti-Kossmann MC. Post-traumatic hypoxia exacerbates neurological deficit, neuroinflammation and cerebral metabolism in rats with diffuse traumatic brain injury. J Neuroinflammation. 2011;8:147. doi:10.1186/1742-2094-8-147.PubMedCrossRef

94.

Wang YC, Lin S, Yang QW. Toll-like receptors in cerebral ischemic inflammatory injury. J Neuroinflammation. 2011;8:134. doi:10.1186/1742-2094-8-134.PubMedCrossRef

95.

Perez-Pinzon MA, Stetler RA, Fiskum G. Novel mitochondrial targets for neuroprotection. J Cereb Blood Flow Metab. 2012;32(7):1362–76. doi:10.1038/jcbfm.2012.32.PubMedCrossRef

96.

Ravati A, Ahlemeyer B, Becker A, Krieglstein J. Preconditioning-induced neuroprotection is mediated by reactive oxygen species. Brain Res. 2000;866(1–2):23–32.PubMedCrossRef

97.

Zhang B, Huang Y, Su Z, Wang S, Wang J, Wang A, et al. Neurological, functional, and biomechanical characteristics after high-velocity behind armor blunt trauma of the spine. J Trauma. 2011;71(6):1680–8. doi:10.1097/TA.0b013e318231bce7.PubMedCrossRef

98.

Busija DW, Gaspar T, Domoki F, Katakam PV, Bari F. Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: mitochondrial targeted preconditioning. Adv Drug Deliv Rev. 2008;60(13–14):1471–7. doi:10.1016/j.addr.2008.03.020.PubMedCrossRef

99.

Saugstad JA. MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J Cereb Blood Flow Metab. 2010;30(9):1564–76. doi:10.1038/jcbfm.2010.101.PubMedCrossRef

100.

Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology. 1997;87(2):361–70.PubMedCrossRef

101.

Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol—a clinical trial. Acta Anaesthesiol Scand. 2012;56(1):30–8. doi:10.1111/j.1399-6576.2011.02585.x.PubMedCrossRef

102.

Bickler PE, Zhan X, Fahlman CS. Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation: role of intracellular Ca²⁺ and mitogen-activated protein kinase signaling. Anesthesiology. 2005;103(3):532–9.PubMedCrossRef

103.

Kapinya KJ, Lowl D, Futterer C, Maurer M, Waschke KF, Isaev NK, et al. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke. 2002;33(7):1889–98.PubMedCrossRef

104.

Kawano T, Kunz A, Abe T, Girouard H, Anrather J, Zhou P, et al. iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite. J Cereb Blood Flow Metab. 2007;27(8):1453–62. doi:10.1038/sj.jcbfm.9600449.PubMedCrossRef

105.

Luo Y, Ma D, Ieong E, Sanders RD, Yu B, Hossain M, et al. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology. 2008;109(5):782–9. doi:10.1097/ALN.0b013e3181895f88.PubMedCrossRef

106.

Zhang JH, Lo T, Mychaskiw G, Colohan A. Mechanisms of hyperbaric oxygen and neuroprotection in stroke. Pathophysiology. 2005;12(1):63–77. doi:10.1016/j.pathophys.2005.01.003.PubMedCrossRef

107.

Hu S, Li F, Luo H, Xia Y, Zhang J, Hu R, et al. Amelioration of rCBF and PbtO2 following TBI at high altitude by hyperbaric oxygen pre-conditioning. Neurol Res. 2010;32(2):173–8. doi:10.1179/174313209x414524.PubMedCrossRef

108.

Jadhav V, Ostrowski RP, Tong W, Matus B, Jesunathadas R, Zhang JH. Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury. Stroke. 2009;40(9):3139–42. doi:10.1161/strokeaha.109.549774.PubMedCrossRef

109.

Kinni H, Guo M, Ding JY, Konakondla S, Dornbos 3rd D, Tran R, et al. Cerebral metabolism after forced or voluntary physical exercise. Brain Res. 2011;1388:48–55. doi:10.1016/j.brainres.2011.02.076.PubMedCrossRef

110.

Liebelt B, Papapetrou P, Ali A, Guo M, Ji X, Peng C, et al. Exercise preconditioning reduces neuronal apoptosis in stroke by up-regulating heat shock protein-70 (heat shock protein-72) and extracellular-signal-regulated-kinase 1/2. Neuroscience. 2010;166(4):1091–100. doi:10.1016/j.neuroscience.2009.12.067.PubMedCrossRef

111.

Ding YH, Luan XD, Li J, Rafols JA, Guthinkonda M, Diaz FG, et al. Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke. Curr Neurovasc Res. 2004;1(5):411–20.PubMedCrossRef

112.

Mazzeo AT, Beat A, Singh A, Bullock MR. The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI. Exp Neurol. 2009;218(2):363–70. doi:10.1016/j.expneurol.2009.05.026.PubMedCrossRef

Title: Preconditioning for Traumatic Brain Injury
Authors: Shoji Yokobori
Anna T Mazzeo
Khadil Hosein
Shyam Gajavelli
W. Dalton Dietrich
M. Ross Bullock
Publication date: 01-02-2013
Publisher: Springer US
Published in: Translational Stroke Research / Issue 1/2013
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI: https://doi.org/10.1007/s12975-012-0226-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Preconditioning for Traumatic Brain Injury

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2013

Moving Towards Preconditioning for Neurological Disorders: Are We Ready for Clinical Trials?

Nrf2 to Pre-condition the Brain Against Injury Caused by Products of Hemolysis After ICH

Biological Networks in Ischemic Tolerance — Rethinking the Approach to Clinical Conditioning

Proceedings of the 2nd Translational Preconditioning Meeting Miami

Hurdles to Clear Before Clinical Translation of Ischemic Postconditioning Against Stroke

Epigenetics and the Environment: In Search of the “Toleroasome” Vital to Execution of Ischemic Preconditioning